Lila Sciences is using connected to automated laboratory equipment to speed up the development of new medicines. The company leverages NVIDIA Nemotron and the NVIDIA Agent Toolkit to design experimental plans, then runs millions of virtual experiments using NVIDIA BioNeMo models to identify the most promising therapy candidates.
Once virtual testing narrows the field, robotic instruments in Lila's AI Science Factory physically synthesize and test the leading candidates. Results from the lab feed back into the AI system to inform the next cycle of design and experimentation. The company is demonstrating this workflow on an immunotherapy approach for B-cell lymphoma that aims to help patients' own immune cells fight cancer.
This is an AI-written summary. The original reporting belongs to @NVIDIA. How we write these · Spot a mistake?